BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 31215231)

  • 1. Clinical analysis of bone metastasis of gastric cancer: incidence, clinicopathological features and survival.
    Wen L; Li YZ; Zhang J; Zhou C; Yang HN; Chen XZ; Xu LW; Kong SN; Wang XW; Zhang HM
    Future Oncol; 2019 Jul; 15(19):2241-2249. PubMed ID: 31215231
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic Value of the Site of Distant Metastasis and Surgical Interventions in Metastatic Gastric Cancer: A Population-Based Study.
    Li Y; Xie D; Chen X; Hu T; Lu S; Han Y
    Technol Cancer Res Treat; 2020; 19():1533033820964131. PubMed ID: 33111644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes and prognostic factors for gastric cancer patients with bone metastasis.
    Mikami J; Kimura Y; Makari Y; Fujita J; Kishimoto T; Sawada G; Nakahira S; Nakata K; Tsujie M; Ohzato H
    World J Surg Oncol; 2017 Jan; 15(1):8. PubMed ID: 28061855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
    Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
    World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study.
    Yu X; Hu F; Yao Q; Li C; Zhang H; Xue Y
    BMC Cancer; 2016 Jul; 16():480. PubMed ID: 27418164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of clinicopathological features and prognosis analysis between carcinoma in the remnant stomach and gastric cancer].
    Li F; Wang Y; Li C; Ma Y; Zhang Y; Li Z; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 May; 21(5):529-534. PubMed ID: 29774934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of the ATM gene linked to poor prognosis for gastric cancer of different nationalities in Xinjiang.
    Han M; Ma L; Qu Y; Tang Y
    Pathol Res Pract; 2017 Aug; 213(8):908-914. PubMed ID: 28647209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prognostic model to predict clinical outcome in gastric cancer patients with bone metastasis.
    Park HS; Rha SY; Kim HS; Hyung WJ; Park JS; Chung HC; Noh SH; Jeung HC
    Oncology; 2011; 80(1-2):142-50. PubMed ID: 21677462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and clinicopathological features of metastasis to liver, lung, bone, and brain from gastric cancer: A SEER-based study.
    Qiu MZ; Shi SM; Chen ZH; Yu HE; Sheng H; Jin Y; Wang DS; Wang FH; Li YH; Xie D; Zhou ZW; Yang DJ; Xu RH
    Cancer Med; 2018 Aug; 7(8):3662-3672. PubMed ID: 29984918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer.
    Qu JL; Qu XJ; Li Z; Zhang JD; Liu J; Teng YE; Jin B; Zhao MF; Yu P; Shi J; Fu LY; Wang ZN; Liu YP
    PLoS One; 2015; 10(6):e0128540. PubMed ID: 26075713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of CD11c indicates favorable prognosis in patients with gastric cancer.
    Wang Y; Xu B; Hu WW; Chen LJ; Wu CP; Lu BF; Shen YP; Jiang JT
    World J Gastroenterol; 2015 Aug; 21(31):9403-12. PubMed ID: 26309367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
    J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicopathological characteristics and prognostic analysis of bone metastasis in gastric cancer patients].
    Zhang H; Zhang RP; Li FX; Quan JC; Liu H; Deng JY; Wang XJ; Liang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Apr; 16(4):354-7. PubMed ID: 23608798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of cancer cells in gastric lavage of gastric cancer patients as an indicator of advanced disease, predictor of tumour aggressive phenotype and independent prognostic factor for poor survival: The endoluminal metastatic pathway of gastric cancer and GL0/GL1 classification.
    Virgilio E; Giarnieri E; Giovagnoli MR; Montagnini M; Proietti A; D'Urso R; Nigri G; Mercantini P; Ramacciato G; Cavallini M; Balducci G
    Cytopathology; 2018 Feb; 29(1):41-48. PubMed ID: 29063636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large tumor size is a poor prognostic factor of gastric cancer with signet ring cell: Results from the surveillance, epidemiology, and end results database.
    Zhou L; Li W; Cai S; Yang C; Liu Y; Lin Z
    Medicine (Baltimore); 2019 Oct; 98(40):e17367. PubMed ID: 31577736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical prognostic value of A FOXM1 related long non-coding RNA expression in gastric cancer.
    Chong DQ; Shan JL; Yang CS; Wang R; Du ZM
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):417-421. PubMed ID: 29424899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological features of gastric adenocarcinoma patients with metachronous distant metastasis.
    Bao J; Qu G; Fu W; Li Y; Song H; Wei Y; Xue Y
    Tumour Biol; 2015 Aug; 36(8):6375-82. PubMed ID: 25921279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes after D2 gastrectomy for early gastric cancer: survival analysis of a single-center experience in China.
    Wang Z; Ma L; Zhang XM; Zhou ZX
    Asian Pac J Cancer Prev; 2014; 15(17):7219-22. PubMed ID: 25227817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AKR1B10, a good prognostic indicator in gastric cancer.
    Yao HB; Xu Y; Chen LG; Guan TP; Ma YY; He XJ; Xia YJ; Tao HQ; Shao QS
    Eur J Surg Oncol; 2014 Mar; 40(3):318-24. PubMed ID: 24406159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.
    An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ
    Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.